Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) to a sell rating in a report issued on Tuesday morning. Several other analysts have also issued reports on the company. Canaccord Genuity Group dropped their price objective on Pacific Biosciences of California from $3.50 to $3.00 and set a buy rating on […]
More Stories
Clean Power Hydrogen (LON:CPH2) Hits New 12-Month Low – What’s Next?
Clean Power Hydrogen Plc (LON:CPH2 – Get Free Report)’s share price reached a new 52-week low on Tuesday . The...
PagerDuty (NYSE:PD) Issues Q4 Earnings Guidance
PagerDuty (NYSE:PD – Get Free Report) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share...
Workday (NASDAQ:WDAY) Announces Earnings Results
Workday (NASDAQ:WDAY – Get Free Report) released its earnings results on Tuesday. The software maker reported $1.89 earnings per share...
Critical Survey: Pinterest (NYSE:PINS) vs. PubMatic (NASDAQ:PUBM)
PubMatic (NASDAQ:PUBM – Get Free Report) and Pinterest (NYSE:PINS – Get Free Report) are both computer and technology companies, but...
Insider Selling: Atlassian Co. (NASDAQ:TEAM) Director Sells 7,948 Shares of Stock
Atlassian Co. (NASDAQ:TEAM – Get Free Report) Director Scott Farquhar sold 7,948 shares of the firm’s stock in a transaction...
AAON, Inc. (NASDAQ:AAON) VP Stephen E. Wakefield Sells 5,750 Shares
AAON, Inc. (NASDAQ:AAON – Get Free Report) VP Stephen E. Wakefield sold 5,750 shares of the business’s stock in a...